Rhumbline Advisers Sana Biotechnology, Inc. Transaction History

Rhumbline Advisers

$113 Billion
Q2 2025

A detailed history of Rhumbline Advisers transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 203,283 shares of SANA stock, worth $837,525. This represents 0.0% of its overall portfolio holdings.

Number of Shares

203,283

Previous 182,134 11.61%

Holding current value

$837,525

Previous $305,000 81.64%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$1.34 - $2.97 $28,339 - $62,812	21,149 Added 11.61%	203,283 $554,000
Q1 2025 Apr 08, 2025	BUY	$1.65 - $4.3 $15,442 - $40,243	9,359 Added 5.42%	182,134 $311,000
Q4 2024 May 29, 2025	SELL	$1.6 - $4.36 $14,974 - $40,805	-9,359 Reduced 5.14%	172,775 $281,000
Q4 2024 Jan 30, 2025	BUY	$1.6 - $4.36 $1,579 - $4,303	987 Added 0.57%	172,775 $281,000
Q3 2024 Nov 12, 2024	SELL	$3.76 - $6.86 $38,032 - $69,388	-10,115 Reduced 5.56%	171,788 $714,000
Q2 2024 Aug 01, 2024	BUY	$5.23 - $10.44 $131,042 - $261,584	25,056 Added 15.97%	181,903 $993,000
Q1 2024 May 09, 2024	BUY	$4.2 - $11.27 $20,424 - $54,806	4,863 Added 3.2%	156,847 $1.57 Million
Q4 2023 Feb 08, 2024	BUY	$2.8 - $4.55 $5,224 - $8,490	1,866 Added 1.24%	151,984 $620,000
Q3 2023 Nov 09, 2023	SELL	$3.77 - $6.23 $10,299 - $17,020	-2,732 Reduced 1.79%	150,118 $580,000
Q2 2023 Aug 08, 2023	BUY	$3.22 - $7.53 $33,030 - $77,242	10,258 Added 7.19%	152,850 $910,000
Q1 2023 May 11, 2023	BUY	$3.11 - $4.92 $13,248 - $20,959	4,260 Added 3.08%	142,592 $466,000
Q4 2022 Feb 14, 2023	BUY	$3.19 - $6.46 $2,456 - $4,974	770 Added 0.56%	138,332 $546,000
Q3 2022 Nov 10, 2022	BUY	$5.58 - $9.04 $42,089 - $68,188	7,543 Added 5.8%	137,562 $825,000
Q2 2022 Aug 11, 2022	BUY	$4.12 - $9.35 $162,010 - $367,670	39,323 Added 43.36%	130,019 $836,000
Q1 2022 May 12, 2022	BUY	$5.24 - $15.58 $28,914 - $85,970	5,518 Added 6.48%	90,696 $749,000
Q4 2021 Feb 10, 2022	BUY	$15.18 - $23.15 $23,210 - $35,396	1,529 Added 1.83%	85,178 $1.32 Million
Q3 2021 Nov 12, 2021	BUY	$16.29 - $25.88 $974,272 - $1.55 Million	59,808 Added 250.86%	83,649 $1.88 Million
Q2 2021 Aug 05, 2021	BUY	$16.65 - $32.14 $47,618 - $91,920	2,860 Added 13.63%	23,841 $469,000
Q1 2021 May 06, 2021	BUY	$23.04 - $43.5 $483,402 - $912,673	20,981 New	20,981 $702,000

Others Institutions Holding SANA

# of Institutions

166

Shares Held

112M

Call Options Held

414K

Put Options Held

295K

View Full List

About Sana Biotechnology, Inc.

Ticker SANA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 190,232,000
Market Cap $784M
Description
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...

More about SANA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Sana Biotechnology, Inc. Transaction History